Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial
Clinical trial NCT04835506 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04835506
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-01
- Primary completion
- 2026-09-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.